{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-008484","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2023-03-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.301354+00:00","generated_at":"2026-06-17T21:43:56.313999+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Immix Biopharma enters ATM facility to sell up to $5M in common stock","bullets":["ATM Sales Agreement with ThinkEquity LLC for up to $5,000,000 of common stock.","Shares sold at market prices; fixed commission of 3.75% of gross proceeds.","Offering made under existing S-3 shelf registration statement declared effective Jan 2023.","Expense deposit of $15,000 paid; legal fee reimbursement up to $50,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-008484","json":"https://secwatch.observer/filing/0001493152-23-008484.json","markdown":"https://secwatch.observer/filing/0001493152-23-008484.md","text":"https://secwatch.observer/filing/0001493152-23-008484.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223008484/0001493152-23-008484-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223008484/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T21:43:56.313999+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"09a8f00febc540656c3f6d8752d536ac90f6ed1a","claim":"Immix Biopharma, Inc. entered into Sales Agreement with ThinkEquity LLC valued at up to $5,000,000 (effective 2023-03-22).","evidence_excerpt":"On March 22, 2023, Immix Biopharma, Inc. (the “Company”) entered into an ATM Sales Agreement (the “Sales Agreement”) with ThinkEquity LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $5,000,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223008484/0001493152-23-008484-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"ThinkEquity LLC"},{"label":"Value","value":"up to $5,000,000"},{"label":"Effective","value":"2023-03-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}